WINTON GROUP Ltd Makes New $329,000 Investment in Sotera Health (NASDAQ:SHC)

WINTON GROUP Ltd purchased a new stake in Sotera Health (NASDAQ:SHC - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The fund purchased 24,049 shares of the company's stock, valued at approximately $329,000.

Several other institutional investors and hedge funds have also made changes to their positions in SHC. Geode Capital Management LLC lifted its holdings in Sotera Health by 19.4% in the third quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company's stock worth $46,026,000 after acquiring an additional 447,186 shares during the last quarter. Maven Securities LTD acquired a new stake in shares of Sotera Health during the 3rd quarter worth approximately $1,670,000. Cerity Partners LLC acquired a new stake in shares of Sotera Health during the 3rd quarter worth approximately $1,489,000. Neo Ivy Capital Management bought a new stake in shares of Sotera Health in the 3rd quarter worth approximately $720,000. Finally, Barclays PLC boosted its position in Sotera Health by 169.8% during the 3rd quarter. Barclays PLC now owns 473,597 shares of the company's stock valued at $7,909,000 after purchasing an additional 298,085 shares during the period. 91.03% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on SHC. Barclays cut their target price on Sotera Health from $17.00 to $16.00 and set an "overweight" rating on the stock in a research note on Friday, February 28th. The Goldman Sachs Group began coverage on shares of Sotera Health in a research report on Friday, December 6th. They issued a "neutral" rating and a $14.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, Sotera Health currently has an average rating of "Moderate Buy" and a consensus price target of $16.00.

Remove Ads

Sotera Health Stock Performance

Shares of NASDAQ:SHC traded down $0.56 on Thursday, hitting $10.94. The company's stock had a trading volume of 314,316 shares, compared to its average volume of 1,174,766. The company has a market capitalization of $3.10 billion, a price-to-earnings ratio of 43.76 and a beta of 1.92. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. Sotera Health has a 12 month low of $10.71 and a 12 month high of $17.08. The stock's 50-day moving average is $12.73 and its two-hundred day moving average is $13.89.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.